Atwood & Palmer »

Corcept Therapeutics Incorporated shares owned by Atwood & Palmer

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Atwood & Palmer from 13F filings

Historical chart of Atwood & Palmer investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Atwood & Palmer consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Atwood & Palmer

Quarter filed Position value Share count Share price at filing
2024-12-31 $23k 464 50.39
2024-09-30 $22k 464 46.28
2024-06-30 $35k 1.1k 32.49

More positions owned by Atwood & Palmer

Palantir Technologies (PLTR)
Alphabet Inc Class C cs (GOOG)
Janus Detroit Str Tr (JAAA)
iShares Lehman 1-3 Year Treas.Bond (SHY)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Ameriprise Financial (AMP)
United Rentals (URI)
Fifth Third Ban (FITB)
Leidos Holdings (LDOS)
American Centy Etf Tr avantis emgmkt (AVEM)
Abbvie (ABBV)
MasterCard Incorporated (MA)
Lockheed Martin Corporation (LMT)
D.R. Horton (DHI)
Gilead Sciences (GILD)

View all positions for Atwood & Palmer

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Novo A/S
Geode Capital Management
Arrowstreet Capital, Limited Partnership
FMR
First Trust Advisors
Jacobs Levy Equity Management
Charles Schwab Investment Management
Northern Trust

View all funds holding Corcept Therapeutics Incorporated